These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1665974)

  • 21. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H; Fujiya S; Aanuma Y; Agishi Y
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.
    Todd PA; Goa KL
    Drugs; 1990 Oct; 40(4):583-607. PubMed ID: 2083515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin increases plasma NO2- and NO3- levels in patients with hypercholesterolemia.
    Nakashima Y; Toyokawa Y; Tanaka S; Yamashita K; Yashiro A; Tasaki H; Kuroiwa A
    Atherosclerosis; 1996 Nov; 127(1):43-7. PubMed ID: 9006803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SC-435, an ileal apical sodium-codependent bile acid transporter inhibitor alters mRNA levels and enzyme activities of selected genes involved in hepatic cholesterol and lipoprotein metabolism in guinea pigs.
    West KL; McGrane M; Odom D; Keller B; Fernandez ML
    J Nutr Biochem; 2005 Dec; 16(12):722-8. PubMed ID: 16169202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of membrane fluidity in cholesterol-poor endothelial cells pre-treated with simvastatin.
    Morita I; Sato I; Ma L; Murota S
    Endothelium; 1997; 5(2):107-13. PubMed ID: 9237044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinational effects of farnesoid X receptor antagonist and statin on plasma lipid levels and low-density lipoprotein clearance in guinea pigs.
    Amano Y; Ishikawa E; Shinozawa E; Shimada M; Miura S; Adachi R; Tozawa R
    Life Sci; 2014 Jul; 108(1):7-12. PubMed ID: 24805868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects.
    Ahnadi CE; Berthezène F; Ponsin G
    Atherosclerosis; 1993 Mar; 99(2):219-28. PubMed ID: 8503950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo effect of simvastatin on lipoprotein cholesteryl ester metabolism in normocholesterolemic volunteers.
    Magot T; Malmendier CL; Ouguerram K; Lontie JF; Lutton C
    Clin Chim Acta; 1991 Jan; 196(1):59-68. PubMed ID: 2022059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs.
    Suzuki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
    Atherosclerosis; 1999 Oct; 146(2):259-70. PubMed ID: 10532682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
    Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
    Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR
    Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.
    Krempler F; Kostner GM; Roscher A; Haslauer F; Bolzano K; Sandhofer F
    J Clin Invest; 1983 May; 71(5):1431-41. PubMed ID: 6304146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism.
    Steinbrecher UP; Witztum JL; Kesaniemi YA; Elam RL
    J Clin Invest; 1983 Apr; 71(4):960-4. PubMed ID: 6300195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture.
    Clerc T; Sbarra V; Domingo N; Rault JP; Diaconescu N; Moutardier V; Hasselot N; Lafont H; Jadot G; Laruelle C; Chanussot F
    Br J Pharmacol; 1996 Aug; 118(7):1862-8. PubMed ID: 8842455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of competitive inhibitors of HMG-CoA reductase.
    Corsini A; Maggi FM; Catapano AL
    Pharmacol Res; 1995 Jan; 31(1):9-27. PubMed ID: 7784310
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholestyramine-induced changes in low density lipoprotein composition and metabolism. I. Studies in the guinea pig.
    Witztum JL; Young SG; Elam RL; Carew TE; Fisher M
    J Lipid Res; 1985 Jan; 26(1):92-103. PubMed ID: 3973515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.